GreenLight is focused on bringing novel cannabinoid medicines to market for the treatment of conditions such as multiple sclerosis, glaucoma, arthritis, epilepsy and cancer

Canadian-listed investment group SOL Global is to acquire a 25 per cent stake in Irish medical cannabis company GreenLight Medicines in a €1.8 million(...)